Annual Operating Expenses
$479.12 M
+$113.15 M+30.92%
December 31, 2021
Summary
- As of February 10, 2025, GBT annual total operating expenses is $479.12 million, with the most recent change of +$113.15 million (+30.92%) on December 31, 2021.
- During the last 3 years, GBT annual operating expenses has risen by +$296.38 million (+162.19%).
Performance
GBT Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Operating Expenses
$145.86 M
+$18.50 M+14.52%
June 30, 2022
Summary
- As of February 10, 2025, GBT quarterly total operating expenses is $145.86 million, with the most recent change of +$18.50 million (+14.52%) on June 30, 2022.
- Over the past year, GBT quarterly operating expenses has increased by +$32.99 million (+29.22%).
Performance
GBT Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
GBT Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +30.9% | +29.2% |
| 3 y3 years | +162.2% | +139.9% |
| 5 y5 years | +301.8% | +497.1% |
GBT Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | at high | -12.7% |
| 5 y | 5-year | at high | -39.1% | at high | -43.0% |
| alltime | all time | at high | -96.7% | at high | -96.7% |
Global Blood Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $145.86 M(+14.5%) |
| Mar 2022 | - | $127.37 M(-7.6%) |
| Dec 2021 | $479.12 M(+30.9%) | $137.91 M(+16.4%) |
| Sep 2021 | - | $118.52 M(+5.0%) |
| Jun 2021 | - | $112.88 M(+2.8%) |
| Mar 2021 | - | $109.82 M(+9.1%) |
| Dec 2020 | $365.97 M(+25.5%) | $100.69 M(+6.3%) |
| Sep 2020 | - | $94.69 M(+13.9%) |
| Jun 2020 | - | $83.16 M(-4.9%) |
| Mar 2020 | - | $87.44 M(-20.2%) |
| Dec 2019 | $291.64 M(+59.6%) | $109.58 M(+59.4%) |
| Sep 2019 | - | $68.74 M(+13.1%) |
| Jun 2019 | - | $60.80 M(+15.8%) |
| Mar 2019 | - | $52.52 M(+0.8%) |
| Dec 2018 | $182.74 M | $52.08 M(+14.5%) |
| Sep 2018 | - | $45.48 M(+7.0%) |
| Jun 2018 | - | $42.49 M(-0.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2018 | - | $42.70 M(+1.9%) |
| Dec 2017 | $119.25 M(+43.4%) | $41.91 M(+43.6%) |
| Sep 2017 | - | $29.18 M(+19.4%) |
| Jun 2017 | - | $24.43 M(+3.0%) |
| Mar 2017 | - | $23.72 M(-13.6%) |
| Dec 2016 | $83.13 M(+79.2%) | $27.46 M(+29.9%) |
| Sep 2016 | - | $21.14 M(+18.7%) |
| Jun 2016 | - | $17.81 M(+6.5%) |
| Mar 2016 | - | $16.72 M(+7.2%) |
| Dec 2015 | $46.39 M(+126.2%) | $15.60 M(+5.6%) |
| Sep 2015 | - | $14.78 M(+71.8%) |
| Jun 2015 | - | $8.60 M(+15.9%) |
| Mar 2015 | - | $7.42 M(+39.6%) |
| Dec 2014 | $20.51 M(+31.0%) | $5.31 M(+2.2%) |
| Sep 2014 | - | $5.20 M(+1.4%) |
| Jun 2014 | - | $5.13 M(+5.3%) |
| Mar 2014 | - | $4.87 M |
| Dec 2013 | $15.66 M | - |
FAQ
- What is Global Blood Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Global Blood Therapeutics?
- What is Global Blood Therapeutics annual operating expenses year-on-year change?
- What is Global Blood Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Global Blood Therapeutics?
- What is Global Blood Therapeutics quarterly operating expenses year-on-year change?
What is Global Blood Therapeutics annual total operating expenses?
The current annual operating expenses of GBT is $479.12 M
What is the all time high annual operating expenses for Global Blood Therapeutics?
Global Blood Therapeutics all-time high annual total operating expenses is $479.12 M
What is Global Blood Therapeutics annual operating expenses year-on-year change?
Over the past year, GBT annual total operating expenses has changed by +$113.15 M (+30.92%)
What is Global Blood Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of GBT is $145.86 M
What is the all time high quarterly operating expenses for Global Blood Therapeutics?
Global Blood Therapeutics all-time high quarterly total operating expenses is $145.86 M
What is Global Blood Therapeutics quarterly operating expenses year-on-year change?
Over the past year, GBT quarterly total operating expenses has changed by +$32.99 M (+29.22%)